1. Home
  2. TRIB vs LGVN Comparison

TRIB vs LGVN Comparison

Compare TRIB & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRIB

Trinity Biotech plc

N/A

Current Price

$0.77

Market Cap

14.0M

Sector

Health Care

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

N/A

Current Price

$1.06

Market Cap

11.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIB
LGVN
Founded
1992
2014
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
11.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
TRIB
LGVN
Price
$0.77
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
189.6K
8.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$709,000.00
Revenue This Year
$13.51
N/A
Revenue Next Year
$13.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.48
52 Week High
$3.44
$1.92

Technical Indicators

Market Signals
Indicator
TRIB
LGVN
Relative Strength Index (RSI) 47.67 76.28
Support Level $0.72 $0.55
Resistance Level $0.79 $1.44
Average True Range (ATR) 0.06 0.11
MACD 0.01 0.06
Stochastic Oscillator 55.25 98.61

Price Performance

Historical Comparison
TRIB
LGVN

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: